Clinical trials
Recruiting Phase 3 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 41 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 10 |
| Novo Nordisk A/S | 10 |
| Hoffmann-La Roche | 6 |
| Pfizer | 5 |
| Amgen | 4 |
| AstraZeneca | 4 |
| Ascletis Pharma (China) Co., Limited | 2 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 2 |
| Chendu DIAO Pharmaceutical Group CO., LTD. | 1 |
| Gan & Lee Pharmaceuticals. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 52 |
| Obesity | 51 |
| Diabetes Mellitus, Type 2 | 10 |
| Sleep Apnea, Obstructive | 3 |
| Body Weight | 2 |
| Diabetes Mellitus | 2 |
| Nutrition Disorders | 2 |
| Weight Loss | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Apnea | 1 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.